Исследование процессов модификации липопротеидов низкой плотности в плазме крови человека

Список литературы

1. Аничков Н.Н. Сердце и сосуды. / В кн.: Частная патологическая анатомия. M.-JL: Медгиз, 1947. Вып. 1.
2. Климов А.Н., Никульская Н. Г. Липиды, липопротеиды и атеросклероз. / С.-Петербург: Питер Пресс, 1995.
3. Тертов В.В., Каплун В. В., Орехов А. Н. Белок-связанные липиды в липопротеидах низкой плотности человека // Бюллетень эксп. биол. и мед. 1995. Т.120. N 8. С. 155−157.
4. Тертов В.В., Каплун В. В., Собенин И. А. и др. Множественно-модифицированные (десиалированные) липопротеиды низкой плотности: физико-химические свойства // Бюллетень эксп. биол. и мед. 1996а. Т.121. N 1. С.42−43.
5. Тертов В.В., Каплун В. В., Собенин И. А. и др. Липидный составмножественно-модифицированных (десиалированных) липопротеидовнизкой плотности // Бюллетень эксп. биол. и мед. 19 966. Т. 122. N 7. i1. С.37−39.
6. Avogaro P., Bittolo Bon G., Cazzolato G. Presence of a modified low density lipoprotein in humans // Atherosclerosis. 1988. V.8. P.79−87.
7. Avogaro P., Cazzolato G., Bittolo Bon G. Some questions concerning a small, more negative"LDL circulating in human plasma // Atherosclerosis. 1991. V.91. P.163−171.
8. Avogaro P., Cazzolato G., Bittolo Bon G. Presense and possible meaning of a more electronegative LDL in human plasma. / In: Oxidative damage and repair: chemical, biological and medical aspects. N.Y.: Pergamon, 1992. P.281−286.
9. Avogaro P., Cazzolato G., Kramsh D.M., et al. Oxidative damage to circulating LDL. / In: Drugs affecting lipid metabolism. Kluver: Dordrecht, 1993. P. 183 190.
10. Balla G., Jacob H.S., Eaton J.W., et al. Hemin: a possible physiological mediator of low density lipoptoein oxidation and endothelial injury // Artetioscler. Thromb. 1991. V.ll. P. 1700.
11. Banelin B., Timmins P.A., Dronet L., et al. Molecular weight and shape of angiotensin-converting enzyme. A neutron scanning scattering study // Biochem. Biophys. Res. Commun. 1988. V.154. P. l 144−1150.
12. Basu M., De T., Das K.K. et al. Glycolipid glycosyltransferases // Method Enzymol. 1987. V.138. P.575−607.
13. Basu M., Basu S., Stoffyn P. Biosynthesis in vitro of sialyl a (2−3)neolactotetrosyl ceramide by a sialyltransferase from embryonic chicken brain // i
14. J. Biol. Chem. 1982. V.257. P.12 765−12 769.
15. Basu M., Hawes J.W., Li Z. et al. Biosinthesis in vitro of SA-Lex and al-3 fukosyltransferases from colon carcinoma cells and embryonic brain tissues // Glycobiology. 1991, V.l. P.527−535.
16. Bergman L.W., Harris E., Kuehl M. Glycosylation causes an apparent block in translation of immunoglobulin heavy chain // J. Biol. Chem. 1981. V.256. N. 2. P.701−706.
17. Bligh E.G., Dyer W.J. A rapid method for total lipid extraction and purification // Can. J. Biochem. Physiol. 1959. Y.37. P.911.
18. Cabezas J.A. The type of naturally occurring sialic acids // Rev. Esp. Fisiol. 1973. V.4. P.307−322.
19. Calfee D.P., Hayden F.G. New approaches to influenza chemoterapy -neuraminidase inhibitors//Drugs. 1998. V.56. P.537−553.
20. Calm J.E., Ketley J.M., Fansano A. et al. Role of Vibrio cholerae neuraminidase in the function of cholerae toxin // Infedt. Immun. 1992. V.60. P.406−415.
21. Cantz M. Sialidosis. / In: Sialic acids (ed. Schauer R.). Vienna: SpringerVerlag., 1980. P.307−320.
22. Cazzolato G., Avogaro P., Bittolo-Bon G. Characterisation of a moreelectronegatively charged LDL subfraction by ion-exchange HPLC // Free
23. Radical Biol. Med. 1991. V. l 1. P.247−253. f7
24. Chatterjee S., Kwiterowich P.O.J. Glycosphyngolipids and plasma lipoproteins: a rewiew // Can. J. Biochem. Cell. Biol. 1984. V.62. P.385−397.
25. Chou M.Y., Li S.C., Li Y.T. Cloning and expression of sialidase L, a NeuAca2−3 Gal-specific sialidase from the Leech (Macrobdella decora) I I J. Biol. Chem. 1996. V.271. P. 19 219−1 ^224.
26. Colman P.M. Influenza virus neuraminidase: structure, antibodies, and inhibitors // Protein Sci. 1994. V.3. P. 1687−1696.
27. Corfield T. Bacterial sialidase roles in pathogenicity and nutrition // Glicobiology. 1992. V.2. P.509.
28. D’Azzo A., Andria G., Striseinglio P. et al. Galactosialidosis. / In: The metabolic and molecular bases of inherited disease. N.Y.: McCraw-Hill, 1995. V.2. P.2825−2838.
29. D’Azzo A., Hoogeveen A., Reuser A.J. et al. Molecular defect in combined p-galactosidase and neuraminidase deficiency in man // Proc. Natl. Acad. Sci. 1982. V.79. P.4535−4539.
30. Dietzschold B. Oligosaccharides of the glycoprotein of rabies virus // J. Virol. 1977. V.23. P.286−93.
31. Egan W. Sialosphingolipids of sea urchin eggs and spermatozoa showing a characteristic composition for species and gamete // Biochim. Biophys. Acta. 1975. V.388. N 1. P.146−151.
32. Feeman W.E. Cholesterol guidelines // Ann. Intern. Med. 1989. Y. l 11. P. 1047j ^1048.
33. Filipovic A., Schwarczmann E., Mraz W., et al. Sialic acid content of low density lipoproteins controls their binding and uptake by cultured cells // Eur J. Biochem. 1989. V.93. P.51−55.
34. Fingerhut R., van der Horst G.T.J., Verheijen F.W. et al. Degradation of gangliosides by the lysosomal sialidase requires an activator protein // Eur. J. Biochem. 1992. V.208. P.623−629.
35. Fogelman A.M., Schechter I., Seager J. et al. Malondialdehyde alteration of LDL leads to cholesteryl ester accumulation in human monocyte macrophage // Proc. Natl. Acad. Sei. USA. 1980. V.77. P.2215−2218.
36. Fraser I.H., Coolbear T., Sarkar M. et al. Increase of sialyltransferase activity in the serum and liver of inflamed rats // Biochim. Biophys. Acta. 1984. V.799. P.102−105.
37. Frish A., Neufeld E.F. A rapid and sensitive assay for neuraminidase: applycation to cultured fibroblast // Annal. Biochem. 1979. V.95. P.222−221.
38. Goldstein J.L., Ho H.S.K., Basu S.K. et al. Binding site on macrophage that mediates uptake and degradation of acetylated LDL producing massive cholesterol deposition // Proc. Natl. Acad. Sei. USA. 1979. V.76. P.333−337.
39. Gorog P, Born GVR. Br. J. Exp. Pathol. Increased uptake of circulating LDLand fibrinogen by arterial walls after removal of sialic acids from theirendotelial surface. 1982, ?3: 447−451
40. Gottschalk A. The chemistry and biology of sialic acids and related substances./ Cambridge: University Press 1960.
41. Greenberg J.P., Packham M.A., Guccione M.A. Survival of rabbit plateletstreated in vitro with chymotrypsVn, plasmin, trypsin, or neuraminidase // Blood. 1979. V.53.N. 5. P.916−927.
42. Gross H.J., Merling A., Moldenhauer G., et al. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid // Blood. 1969. V.87. P.5113−5126.
43. Gross G.A., Takle G.B. The surface trans-sialidase family of Trypanosona cruzi //Annu. Rev. Microbiol. 1993. V.47. P.385−411.
44. Haverkamp J., Veh R., Sander M. Demonstration of 9-O-acetyl-N-acetylneuraminic acid in brain gangliosides from various vertebrates including man//Hoppe Seylers Physiol. Chem. 1977. V.358. N. 12. P.1609−1612.
45. Holmgren J., Elwing H., Fredman P., et al. Structure and function of gangliosides./N.Y.: Plenum Press, 1980. P.453−470
46. Itzstein von M., Thomson R.S. Sialic acids and sialicacid-recognising proteins: drug discovery targets and potential glycopharmacuticals // Curr. Med. Chem. 1997. V.4. P.185−210.
47. Jaakkola O., Solakivi T., Tertov V.V., et al. Characteristics of low density lipoprotein subfractions from patients with coronary artery disease // Coron. Artery Dis. 1993. V.4. P.379−385.
48. Kijima-Suda I., Miyamoto Y., Toyoshima S., et al. Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate having sialyltransferase inhibiting activity // Cancer
49. Res. 1986. V.46. P.858−862.
50. Kita T., Yokode M., Ishii K. et al. The role of atherogenic low density lipoproteins (LDL) in the pathogenesis of atherosclerosis // Ann. N.Y. Acad. Sei. 1990. V.598. P.188−193.
51. Kobata S. Use of endo- and exoglycosidases for structural studies of glycoconjugates // Anal. Biochem. 1979. V.100. P. l-14.
52. Kochetkov N.K., Glukhoded I.S. Isolation and characterization of a sialoglycolipid from the sea urchin Strongylocentrotus intermedius // Biochim. Biophys. Acta. 1973. V.326. N. 1. P.74−83.
53. Kohn L.D., Consiglio E., DeWolf M.J., et al. Structure and function of gangliosides./ N. Y.: Plenum Press, 1980. P. 487−530
54. Kolb H., Friedrich E., Suss R. Lectin mediates homing of sialidase-treated erythrocytes of the liver as revealed by scintigraphy // Hoppe Seylers Z Physiol. Chem. 1981. V.362. N. 12. P.1609−1614.
55. Krantz M.J., Lee M.C., Hung P.P. Carbohydrate groups in the major glycoprotein of Rous sarcoma virus // Nature. 1974. V.248. N 450. P.684−686.
56. La Belle M., Krauss R.M. Differences in carbohydrate content of low densityilipoproteins associated with low density lipoprotein subclass patterns // J. Lipia Res. V.31. P.1577−1588.
57. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriofage T4 //Nature. 1970. V.227. P.680.
58. Lammers G., Jamieson J.C. The role of cathepsin D-like activity in the release of Gaipi-4GlcNAca2−6 sialyltransferase from rat liver Golgi membrane during acute phase responce // Biochem. 1981. V.304. P.1506−1510.
59. Leiser M., Harms E., Kern H. et al. Ganglioside GM3 sialidase activity in fibroblast of normal individuals and of patiens with sialidosis and mucolipidosis // Biochem. J. 1989. Y.260. P.69−74.
60. Lin R.C., Dai J., Lumeng L., et al. Serum low dencity lipoprotein of alcoholic patients is chemicaly modified in vivo and induces apolipoprotein E synthesis in macrophages // J. Clin. Invest. 1995. V.95. P.1979−1986.
61. Lis H., Sharon N. Protein glycosylation // Eur.J.Biochem. 1993. V.218. P. 1−27.
62. Lopes-Virella M.F., Klein R.L., Lyons T.J. et al. Glicosylation of LDL enhances cholesteryl ester synthesis in human-derived macrophages // Diabets. 1988. V.37. P.550−557.
63. Malmendier C.E., Deleroix C., Fonteine M. Effect of sialic acids removal in human LDL catabolism in vivo // Atherosclerosis. 1980. V.37. P.227−284.
64. Margolis R.K., Margolis R.U. Complex Carbohydrates of nervous tissue./ N. Y.: Plenum Press, 1979. P.45−73.
65. Matsuuchi L., Sharon J., Morrison S.L. An analysis of heavy chain glycopeptides of hybridoma antibodies: correlation between antibody specificity and sialic acid content//J. Immunol. 1981. V.127. N. 5. P.2188−2190.
66. Millar J.S., Anber V., Shepherd J., et al. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions // Atherosclerosis. 1999. V.145. P.253−260.
67. Miyagi T., Konno K., Emori Y. et al. Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase // J. Biol. Chem. 1993. V.268. P.26 435−26 440.
68. Miyagi T., Sagawa J., Konno K. et al. Biochemical and immunological studies on two distinct gangliosid-hydrolising sialidase from the particulate fraction of the rat brain // J. Biochem. 1990a. V.107. P.787−793.
69. Miyagi T., Sagawa J., Konno K. et al. Immunologycal discrimination of intralysosomal, cytosolic, and two membrane sialidase present in rat tissues // J. Biochem. 1990b. V.107. P.794−798.
70. Miyagi T., Tsuiki S. Purification and characterisation of cytosolic sialidase from rat liver//J. Biol. Chem. 1985. V.260. P.6710−6716.
71. Montreuil J. Structural similarity of the terminal carbohydrate sequencese of glycoproteins and glycolipids // Pure Apple. Chem. 1975. V.42. P.431−497.
72. Montreuil J. Primary structure of glycoprotein glycans: basis for molecular biology of glycoproteins // Adv. Carbohyd. Chem. Biochem. 1980. V.37. P. 158 223.
73. Nagai Y., Hoshi M. Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12 // Biochemistry. 1977. V.16. N. 16. P.3687−3692.
74. Olden K., Parent J.B., White S.L. Carbohydrate moiety of glycoproteins. A reevaluation of their function // Biochem. Biophys. Acta. 1982. V.650. P.209−232.
75. Orekhov A.N., Tertov V.V., Mukhin D.N. Desialyla low density lipoprotein -naturally occuring lipoprotein with atherogenic potency // Atherosclerosis. 1991. V.86. P. 153−161.
76. Orekhov A.N., Tertov V.V., Pokrovsky S.N. et al. Blood serum atherogenicity assosiated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of LDL and an approach to its elimination // Circ. Res. 1988. V.62. P.421−429.
77. Orekhov A.N., Tertov V.V., Sobenin I.A. et al. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation // J. Lipid Res. 1992. V.33. P.805−807.
78. Packard C.J., Shepherd J. Low density lipoprotein metabolism // Prog. Clin. Biol. Res. 1988. V.255. P. l 17−123.
79. Paulson J.C., Colley L.J. Glycosyltransferases. Structure, localisation and control of cell type-spesific glycosylation // J. Biol. Chem. 1989. V.264. P.17 615−17 618.
80. Pelt van J., Kamerling J.P., Vliegenthart J.E. et al. A comparative study of the accumulated sialic acide-contaning oligosaccarides from cultured human galactosialidosis and sialidosis fibroblast // Clin. Chim. Acta. 1988a. V.174. P.325−335.
81. Pelt van J., Kamerling J.P., Vliegenthart J.E. et al. Isolation and structural characterisation of sialic acide-contaning storage material from mucopolilipids I (sialidosis) fibroblasts //Biochim. Biophys. Acta. 1988b. V.956. P.36−45.
82. Pelt van J., Kamerling J.P., Vliegenthart J.E. et al. Structural analysis of O-glycosidic type of sialyloligosaccharide-alditors derived from urinal glycopeptides of a sialidosis patiens // Eur. J. Biochem. 1988c. V.174. P. l83−187.
83. Reuter G., Gabius H.J. Review sialic acids: structure analysis — metabolism -occurence — recognition // Biol. Chem. Hoppe Seyler. 1996. V.377. P.325−342.
84. Rodriguez-Iturbe B., Katiyar V.N., Coello J. Neuraminidase activity and free sialic acid levels in the serum of patients with acute poststreptococcal glomerulonephritis // The New Eng. J. of Medicine. 1981. V.304. P. 1506−1510.
85. Roggentin P., Schauer R., Heyer L.L. et al. Micro review: The sialidase superfamily and its spread by horisontal gene transfer // Mol. Microbiol. 1993. V.9. P.915−921.
86. Roseman S. The synthesis of complex carbohydrates by multiglycosyltransferases systems and their potential funktion in intracellular adhesion//Chem. Phys. Lipids. 1970. V.5. P.270−297.
87. Rosner H. Isolation and preliminary characterization of novel polysialogangliosides from embryonic chick brain // J. Neurochem. 1981. V.37. N. 4. P.993−997.
88. Rothender M., Krempler F., Kostner G.M. Interaction of various lipoproteins from normal and dyslipoproteinemic plasma with mouse peritoneal macrophages //Ann. Biol. Clin. (Paris). 1988. V.46. P.30−34.
89. Saito M., Yu R.K. Biochemistry and function of sialidase. / In: Biology of sialic acids. N.Y.: Plenum Press, 1995. P.261 -313.
90. Sasaki R., Takaku F., Lin Y.L. Sialyltransferase activity as a marker for the determination of limphocytes // Clin. Exp. Immunol. 1982. V.47. P.381−388.
91. Sato K., Miyagi T. Genomic organisation and the 5"-upstream sequence of the rat cytosolic sialidase gene // Glycobiology. 1995. V.5. P.511−516.
92. Sato K, Miyagi T. Involvment of an endogeneous sialidase in skeletal muscle cell differentiation // Biochem. Biophys. Res. Commun. 1996. V.221. P.826−830.
93. Schachter H., Roseman S. Mammalian glycosyltransferases: their role in the synthesis and function of complex carbohydrates and glycolipids. / In: The biochemistry of glycoproteins and proteoglycans. N.Y.: Plenum Press., 1980. V.85. P.160.
94. Schauer R. Chemistry, methabolism and biology function of sialic acids // Adv. Carbohydr. Chem. Biochem. 1982a. V.40. P.131−234.
95. Schauer R. Sialic acids. Chemistry, metabolism and funktion. / 1982b. 195p.
96. Schauer R. Role of sialic acids // Trends Biochem. 1985. V.7. P.357−360.
97. Schauer R., Keim S., Reuter G. et al. Biochemistry and role of sialic acids. / N.Y.: Plenum Press, 1995. P.7−67.
98. Schauer R., Rudiger W.V., Wember M. Demonstration of neuraminidase activity in human blood serum and human milk using a modified, radioactively labelled alpha 1-glycoprotein as substrate // Hoppe Seylers Z. Physiol. Chem. 1976. V.357. N. 4. P.559−566.
99. Schenkman S., Eichinger D., Pereira M.E. et al. Structural and funktional properties of Trypanosoma trans-sialidase // Ann. Rev. Microbiol. 1994 V.48. P.499−523.
100. Schneider-Jackob H.R., Cantz M. Lysosomal and plasma membrane ganglioside GM3 sialidase of cultured human fibroblast-differensiation by detergent and inhibitors // Biol. Chem. Hoppe Seyler. 1991. V.377. P.443−450.1. N.
101. Senn H. J, Orth M., Fitzke E. et al. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins // Eur. J. Biochem. 1989. V.181. P.657−662.
102. Sharaev P.N., Gumiarova G., Koz’min F.G. et al. The determination of sialidase activity in the blood serum and saliva//Klin. Lab. Diagn. 1993. V.6. P.15−16.
103. Shen M.M.S., Krauss R.M., Lindgren F.T., et al. Heterogenity of serum low density lipoproteins in normal human subjects // J. Lipid Res. 1981. V.22. P.236−244.
104. Sonmer H., Suer S., Gungor Z. et al. Tissue and serum sialidase levels in breast cancer // Cancer Lett. 1999. V.136. P.75−78.
105. Slomiany A., Slomiany B.L. Structures of the acidic oligosacgarides isolated from rat sublingual glycoprotein//J. Biol. Chem. 1979. V.249. P.7742−7746.
106. Steinberg D., Parthasarathy S., Carew T.E. et al. Modification of LDL that increase its atherogenecity//N. Engl. J. Med. 1989. V.320. P.915−924.
107. Straus D.C., Purdy C.W., Loan R.W. et al. In vivo production of neuraminidase by Pasteurella haemolytica in marked stressed cattle after natural infection // Curr. Microbiol. 1998. V.37. P.240−244.
108. Sugita M. Studies on the glycosphingolipids of the starfish, Asterina pectinifera. II. Isolation and characterization of a novel ganglioside with an internal sialic acid residue // J. Biochem. (Tokyo). 1979 V.86. N. 2. P.289−300.
109. Taniguchi T., Ishikava Y., Tsunemitsu M., et al. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by asialo low density lipoproteins //Arteriosclerosis 1989. V.9. P.767−769.
110. Tertov V.V., Bittolo-Bon G., Sobenin I.A. et al. Naturally occuring modified LDL are similar if not identical: more electronegative and desialylated lipoprotein subfraction//Exp. Mol. Biol. 1995. V.62. P.166−172.
111. Tertov Y.V., Kaplun V.V., Dvoryantsev S.N. et al. Apolipoprotein B-boundlipids as a marker for evaluation of low density lipoprotein oxidation in vivo //
112. Biochem. Biophys. Res. Commun. 1995. V.214. P.608. i
113. Tertov V.V., Orekhov A.N. Metabolism of native and naturally occuring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima // Exp. Mol. Pathol. 1997. V.64. P.127.
114. Tertov V.V., Orekhov A.N., Martsenyuk O.N. et al. LDL isolated from the blood of patients with coronary heart desease induce the accumulation of lipids in human aortic cells // Exp. Mol. Pathol. 1989. V.50. P.337−347.
115. Tertov V.V., Orekhov A.N., Sobenin I.A. et al. Three types of naturally occuring modified lipoproteins induce-intracellular lipid accumulation due to lipoprotein aggregation // Circ. Res. 1992. V.71. P.218−228.
116. Tertov V.V., Orekhov A.N., Sobenin I.A. et al. Carbohydrate content of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease // J. Lipid Res. 1993. V.34. P.365−375.
117. Tertov V.V., Sobenin I.A., Gabbazov Z.A. et al. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins //Biochem. Biophys. Res. Commun. 1989. V.163. P.489.
118. Tertov V.V., Sobenin I.A., Gabbazov Z.A. et al. Multiple-modified desialylated LDL that cause intracellular lipid accumulation. Isolation, fractionation and characterisation//Lab. Investigation. 1992. Y.67. P.665−675.
119. Tertov V.V., Sobenin I.A., Orekhov A.N. Similarity between naturally occuring modified desialylated, electronegative and aortic low density lipoprotein // Free Rad. Res. 1996. V.25. P 313−319.i
120. Tettamanti G., Morgan I.G., Gombos G. et al. Sub-synaptosomal localization of brain particulate neuraminidase // Brain research. 1972. V.47. P.515−518.
121. Tsegenidis T., Karamanos N.K. // J. Liq. Chrom. and Rel. Technol. 1998. V.21. P.793−802.
122. Varki A. Biological roles of oligosaccharides: all theores are correct // Glycobiolog. 1993. V.3. P.97−130.
123. Vaskovsky V.E., Kostetsky E.Y., Vasendin I.M. A universal reagent for fosfolipid analysis//J. Chromatogr. 1975. V.114. P.129.
124. Vedie B., Mayra I., Pech M.A., et al. Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography // J. Lipid. Res. 1991. V.32. P.1359−1369.
125. Warner T.G., Chang J., Ferrari J. et al. Isolation and properties of a soluble sialidase from the culture fluid of Chinese hamster ovary cells // Glycobiology. 1993. V.3. P.455−463.
126. Warren L. The thiobarbituric acid assay of sialic acids // J. Biol. Chem. 1959. V.234. P.1971.
127. Wenger D.A., Tarby T. J,. Wharton C. Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and p-galactosidase deficiences //j
128. Biochem. Biophys. Res. Commun. 1978. V.82. P.589−595.
129. Yaari A. Mobility of human red bid cells of different age groups in an electric field//Blood. 1969. V.33. P. 159−163.
130. Yagi K. Lipid peroxidation. Assay for blood plasma and serum // Methods Enzymol. 1984. V.105. P.328.
131. Zeigler M., Sury V., Bach G. The identification of lysosomal ganglioside sialidase in human cells // Eur. J. Biochem. 1989. V.183. P.455−458.